CereGate is a Munich-based clinical-stage neurotechnology company founded in 2019 that develops brain-computer interface (BCI) software for treating neurological disorders. Its hardware-agnostic software platform runs on Boston Scientific deep brain stimulation systems and is in clinical investigation for freezing of gait in Parkinson's patients, an indication with few remaining options once medication and standard stimulation stop working. The company also conducts research in spinal cord stimulation.
1
Round
1
Industry
5
Tags
Oct 14, 2026
Latest raise
Funding activity · 1 round
Oct 14, 2026
Series C+
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
